Slide One
HYBRID 2021 START-UPS

HYBRID 2021:

CALL FOR

EXPRESSION

OF INTEREST

START-UPS IN IMMUNOLOGY AND INFLAMMATORY DISORDERS

A call for expression of interest dedicated to start-ups evolving in the field of immunology and inflammatory disorders is now open!
We are looking for start-ups working in the field of:

  • Check-points targets
  • Immunomodulation
  • Systemic auto-immune diseases (lupus, arthritis, vasculitis, scleroderma)
  • Organ-specific auto-immune diseases (inflammatory bowel diseases, neuro-inflammation)
  • Diagnostic tools
  • Microbiota (immunogenic bacteria)
  • Biomarkers
  • e-health solutions & AI based solutions (incl. devices)

SUBMISSION

Apply and join the HYBRID 2021 event!

Interested start-ups must send applications and ID cards to: callforinterest@hybridays.com

Application must be written in English and should not exceed 5 pages.
It must include the following components:

  • Short description of the company (max. 15 lines)
  • Board & Team
  • Description of the tackled issue(s) and the market (diseases / group of diseases, unmet medical needs, etc.…)
  • Know-how, scientific approach, technologies, and collaborations - Innovation and Intellectual Property (if no I.P., why?)
  • Business Model
  • Development plan (scientific, technologic, clinic, financial, HR, business development)

PROCESS

BENEFIT FROM A PERSONALIZED COACHING!

Applications will be reviewed by an independent joint steering committee composed of industrials, academics, and investors.

15-20 companies will be selected and benefit from a personalized coaching to fine-tune their pitch in front of the participating international decision-makers and perform to their B2B meetings with academic researchers, biotechs & industries.

For any question or additional information, do not hesitate to contact us at: callforinterest@hybridays.com